COPPELL, Texas--(BUSINESS WIRE)--Apr. 19, 2016--
Incorporated (NASDAQ: MTEX), a global health and wellness company
committed to transforming lives to make a better world, announced it has
assembled a group of top-tier, independent scientists to lead its Global
Scientific Advisory Board that will support the company’s continued
commitment to providing groundbreaking, science-backed nutritional
supplements to its worldwide customer base.
“The members of Mannatech’s Global Scientific Advisory Board are
committed to science and the truth that their research and findings
bring,” said Mannatech’s CEO and President, Alfredo “Al” Bala.
“Mannatech has built its worldwide business on science-backed product
technology, and this group will help us continue that tradition and take
us into new, transformational areas of health and wellness, while
ensuring we stay on the path of scientific proof and validation.”
This Global Scientific Advisory Board is part of CEO
and President Al Bala’s vision for ensuring that Mannatech delivers
innovative nutritional technology and products that are supported by
clinical trials and scientific validation. The board safeguards that
Mannatech products are what they say they are and can provide real
results by improving the overall wellness of customers*.
Mannatech’s Global Scientific Advisory Board is specifically charged to
review each new and existing product to ensure ingredients and
formulations are kept to a high standard and are in-line with the latest
research. The board will also be called upon to make suggestions for new
products. Additionally, board members will provide education and
training to Associates and customers on health and wellness topics.
The Mannatech Global Scientific Advisory Board consists of third-party,
independent scientists from around the world. The board members include:
Azita Alavi, BSc(Hons), M.Phil. Ph.D.
Richard J. Bloomer, Ph.D.,
Stephen Boyd, MD, Ph.D.
Charl Marais, DEmed
Francesco Marotta, MD Ph.D.
Erika Nelson, Ph.D.
Chandan Prasad, MS, Ph.D.
Emma Roca, MS
William Sanchez, MD
Mannatech’s Senior Global Wellness Director, Dr. Steve Nugent, will
serve as Chairman of the Global Scientific Advisory Board and Dr.
Rolando Maddela, Mannatech’s Director of Clinical Research and
Scientific Affairs, will serve as the Executive Secretary. Mr. Tait
Switzer, Vice President of Research and Development, will also support
the scientific advisory board members.
“Innovative technology supported by a sound scientific foundation is at
the heart of Mannatech’s products and ultimately, its success,” said Dr.
Nugent. “Mannatech’s Global Scientific Advisory Board will ensure that
we remain on the cutting edge of nutritional technology. This is an
amazing group of minds that are focused on making the world a better
place. By working together, we can find more ways to improve the health
and wellness of as many people as possible. These individuals will
retain their independence, but their position on the advisory board will
give them a unique vantage point to the health and wellness community
around the globe, as well as an opportunity to share their point of view
with an audience that is in need of their service.”
Mannatech’s commitment to science includes clinical studies on its
product technology and a global patent program. Since its founding,
Mannatech has invested more than $50 million in research and development
that includes a clinical testing program for a number of its products
that helps supports core product claims and ensures that the company
delivers what is promised. Mannatech’s core technology has been included
in 17 human clinical trials that have been published, 12 of which were
double-blind, placebo-controlled studies — the gold standard for product
Mannatech’s Global Science Advisory Board was introduced to thousands of
its leaders and independent sales Associates earlier this month at
MannaFest 2016. The board will meet and provide input to Mannatech on a
To begin transforming your life or the lives of those around you, please
*This statement has not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat, cure
or prevent any disease.
Mannatech, Incorporated, offers a profound wellness experience through a
financially rewarding opportunity that makes a difference in the lives
of people across the world. Through its innovative glyconutrition
products, Mannatech transforms lives, providing an unprecedented level
of natural wellness, freedom and purpose. With more than 20 years of
experience and operations in more than 25 countries, Mannatech is
committed to transforming lives. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160419006298/en/
Source: Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245